Scottish Health Technologies Group
Group meetings
SHTG is chaired by SGHD and members include territorial and special NHS boards, health economists, lay representatives and industry.
SHTG publications
Horizon scanning report of evidence based assessments
SHTG receive a quarterly report of technologies that will have significant implications for patient care in Scotland. It summarises evidence of clinical and cost effectiveness available in:
- NICE technology appraisals
- outputs from our health technology assessment programme
- and other UK and international health technology assessments.
From this report, SHTG will:
- select technologies to further research the clinical and cost effectiveness evidence
- provide advice on implementation
- provide costing tools, including clinical and resource impact reports and costing templates .
In these cases SHTG can request further detailed work from NHS QIS and National Procurement, including Evidence Notes and clinical and resource impact reports.
Get SHTG Evidence-based assessment reports
Evidence Notes
Evidence Notes may be requested on particular topics or clinical areas where SHTG judge more evidence is required. Evidence Notes do not make recommendations; they are short summaries which highlight key issues for decision makers within NHSScotland and direct them to robust sources of evidence (or lack of evidence). Evidence Notes take approximately 3 months to produce from approval of the topic.
Clinical and resource impact reports
These reports provide estimates of the resources and costs required at national and NHS board levels to implement key evidence-based recommendations. The starting point is to identify the changes required from the current pathway and the related resources required to implement and operate the new pathway.
Get clinical and resource impact reports
SHTG remit
Horizon scanningTo identify existing and new non-drug technologies, including new devices which are likely to have significant implications for patient care in NHSScotland, and areas where there may be evidence to support disinvestment.
Assessment and appraisal
To ensure that assessment and appraisal of the effectiveness of such technologies is carried out as needed, taking account of assessment and appraisal work being carried out both nationally and internationally, eg the National Institute for Health and Clinical Excellence (NICE) and the Canadian Agency for Drugs and Technologies in Health (CADTH).
Facilitating implementation and dissemination
To facilitate the implementation by NHSScotland of key evidence-based recommendations on technologies made in SIGN guidelines, NHS QIS health technology assessments and NICE technology appraisals.
SHTG processes
SHTG processes involve NHS boards, clinicians, manufacturers and public partners:
- NHS boards information on topics of interest, to include disinvestment opportunities, are sought from NHS boards and regional planning groups
- Clinicians interested clinicians are identified to advise and work on appraisals
- Manufacturers may be asked to provide information to NHS QIS and National Procurement as part of their standard procedures.
- Public partners topics suggested by NHS boards are informed by their ongoing relationship with the public and patients
Refer a topic to SHTG
If you would like to submit a topic for consideration by SHTG, please complete the
topic referral form and return to Doreen.Pedlar@nhs.net.
More information
- HTA Report 12: Topical negative pressure therapy for wounds
- 6 May 2010 - Disinvestment challenge seminar
- Coverage with evidence development in NHSScotland
- View the 2008/09 SHTG Annual Report
- Find out more about this group
- Receive email updates including the latest SHTG publications
For more information email SHTG.qis@nhs.net or contact:
Doreen Pedlar
Project Co-ordinator
Tel: 0141 225 6998


